SCHEMBL20915784

SCHEMBL20915784

Cc1c(Cc2ccc(S(=O)(=O)N(C)C)cc2)c2nc(C(C)(C)O)ccc2n1C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ RECQL P46063 1/20 0.38
▸ PTGDR2 Q9Y5Y4 2/20 0.37
▸ GAA P10253 1/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ LDHA P00338 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ ALDH1A1 P00352 4/20 0.33
▸ LMNA P02545 1/20 0.33
▸ ABCC9 O60706 1/20 0.33
▸ ABCC8 Q09428 1/20 0.33
▸ KCNJ11 Q14654 1/20 0.33
▸ KCNJ8 Q15842 1/20 0.33
▸ LOXL2 Q9Y4K0 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ KLKB1 P03952 1/20 0.32
▸ PKM P14618 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19249408 0.88 GPR119 (0.39) NPSR1MEN1KMT2ARECQLPTGDR2
SCHEMBL20915666 0.77 LOXL2 (0.54) LOXL2
SCHEMBL19249370 0.77 LOXL2 (0.54) LOXL2
Hydrochloric Acid SCHEMBL20915330 0.76 LOXL2 (0.54) LOXL2
Hydrochloric Acid SCHEMBL20915811 0.76 LOXL2 (0.54) LOXL2
Hydrochloric Acid SCHEMBL29596428 0.76 LOXL2 (0.54) LOXL2
SCHEMBL19249890 0.75 LOXL2 (0.43) LOXL2
SCHEMBL19249403 0.74 PTGS1 (0.38) NPSR1MEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL19249386 0.69 GPR119 (0.41) NPSR1MEN1KMT2APTGDR2SMN1; SMN2
SCHEMBL20488966 0.66 LMNA (0.50) NPSR1MEN1KMT2APTGDR2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10717734-B2 Indole and azaindole haloallylamine derivative inhibitors of lysyl oxidases and uses thereof PHARMAXIS LTD. (AU) 2020-07-21 — — US disclosed
US-20190119269-A1 INDOLE AND AZAINDOLE HALOALLYLAMINE DERIVATIVE INHIBITORS OF LYSYL OXIDASES AND USES THEREOF PHARMAXIS LTD. (AU) 2019-04-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10717734-B2 Indole and azaindole haloallylamine derivative inhibitors of lysyl oxidases and uses thereof IDO1, IDO2, INMT NPSR1 1867/4885MEN1 3052/4885KMT2A 540/4885
US-20190119269-A1 INDOLE AND AZAINDOLE HALOALLYLAMINE DERIVATIVE INHIBITORS OF LYSYL OXIDASES AND USES THEREOF IDO1, IDO2, INMT NPSR1 1867/4885MEN1 3052/4885KMT2A 540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback